Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cetuximab plus triplet

ABSTRACT: Primary objectives: To investigate the rate of patients submitted to surgery for liver metastases after a triplet induction chemotherapy (CPT-11, 5-fluorouracil-leucovorin, oxaliplatin) plus Erbitux in patients with liver metastases from colorectal cancer Primary endpoints: Resection rate of liver metastases

DISEASE(S): Liver Metastases From Colorectal Cancer

PROVIDER: 2518979 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

Project description:Triplet repeat siRNAs as found amplified in diseases such as Huntingtons disease can be used to kill cancer cells

2018-01-12 | GSE104552 | GEO

Multicenter PhaseII study of Combination FOLFIRI with Erbitux in advanced/metastatic colorectal cancer: EGFR positive and KRAS wild type

Project description:Interventions: FOLFIRI (CPT-11, 5-FU bolus, 5-FU infusional, l-LV)+ Erbitux Cetuximab 400 mg/m2(day1) Cetuximab 250 mg/m2/week, (except day 1) CPT-11 100 or 150 mg/m2/bi-week l-LV 200 mg/m2/bi-week 5-FU/bolus 400 mg/m2/bi-week 5-FU/infusional2,400 mg/m2/bi-week (day 1-3) Primary outcome(s): Response rate Study Design: Single arm Non-randomized

| 2617576 | ecrin-mdr-crc

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

Project description:The aim of the trial is to compare the objective response rates of FUDR/Oxaliplatin HAI plus CPT-11 and FOLFOXIRI chemotherapy in patients with initially non-resectable metastatic colorectal cancer liver metastases. The patients will be treated with systemic FOLFOXIRI chemotherapy or FUDR/Oxaliplatin hepatic arterial infusion with CPT-11 systemic chemotherapy.

| 2284699 | ecrin-mdr-crc

Transcriptomic comparison of chemosensitive and chemoresistant cells

Project description:First, in a model of xenografts induced with HT-29 human colon cancer cells, we demonstrated that the transcription factor NF-kB was involved in the resistance to CPT-11. Then, from one tumor treated with CPT-11 plus a NF-kB inhibitor, we established a resistant cell line to CPT-11. The aim of this study was to compare the expression of genes involved in the signaling pathway of NF-kB between the sensitive and the resistant cell lines and to identify other genes (target or not of NF-kB) which the expression was modified when the resistant phenotype was acquired.

2012-08-23 | GSE23433 | GEO

Gene expression data of QRsP-11 mouse fibrosarcoma cell line and its liver metastatic subline

Project description:Mouse QRsP-11 fibrosarcoma cells were injected into the spleens of mice to isolate sub-populations of tumor cells that colonize to the liver. Cells from liver metastatic nodules were established in vitro and subsequently injected intrasplenically for further cycles of selection. After 12 cycles of in vivo selection, the cell subline LV12 was established. Intravenous injection of LV12 cells produced liver metastases than QRsP-11 cells, whereas the incidence of lung metastases was similar to that of QRsP-11 cells. LV12 cells exhibited adhesiveness to liver-derived but not to lung-derived endothelial cells. DNA chip analysis indicated that an amphoterin-induced gene and open reading frame 2 (Amigo2) was overexpressed in LV12 cells. Knockdown of Amigo2 expression by siRNA in LV12 cells attenuated liver endothelial cell adhesion. Ex vivo imaging showed that siRNA-mediated suppression of Amigo2 in luciferase-expressing LV12 cells reduced attachment to liver tissue to the same level as that observed with QRsP-11 cells. Moreover, Amigo2-knockdown by siRNA inhibited liver metastasis. Amigo2 expression in human cancer cells was higher in liver metastatic lesions than in primary lesions of colon and gastric cancer specimens. These data indicated that Amigo2 is involved in tumor cell adhesion to liver endothelial cells and formation of liver metastases.

2017-03-27 | GSE88923 | GEO

Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer

Project description:To see if Disease Free Survival (DFS) is improved when complete surgical resection of liver metastases (R0) is followed by chemotherapy with CPT-11 and 5-FU/FA as FOLFIRI regimen, compared to 5-FU/FA alone.

| 2015253 | ecrin-mdr-crc

Effect of CWG-cPIP on CAG/CTG triplet repeat mouse brain

Project description:Effect of CWG-cPIP on CAG/CTG triplet repeat mouse brain

| PRJNA867693 | ENA

Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

Project description:Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

| PRJNA413038 | ENA

Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer

Project description:The purpose of this study is to evaluate the efficacy and safety of fluorouracil (5-FU), levofolinate calcium (l-LV), oxaliplatin (L-OHP) and irinotecan hydrochloride hydrate (CPT-11) (FOLFOXIRI) plus bevacizumab in untreated metastatic colorectal cancer patients who harbor Uridine diphosphate (UDP)-glucuronosyl transferase 1A1 (UGT1A1) *1/*1, *1/*6 or *1/*28.

| 2194080 | ecrin-mdr-crc

Transcriptomic comparison of chemosensitive and chemoresistant cells

2012-08-23 | E-GEOD-23433 | biostudies-arrayexpress